Restera
PrivateLast Round
Series A
Jun 1, 2023
Total Funding Raised
$81.33M
Company Overview
Restera operates in Healthcare & Life Sciences and is based in Santa Clara, California. Its latest recorded funding round was a Series A round in June 2023.
Restera is a medical technology company developing an intelligent neurostimulation system for the treatment of obstructive sleep apnea.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Restera Comparables
Compare Restera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cryosa | 90% | |
| StimAire | 89% | |
| XII Medical | 88% |
For institutional investors. Book with your work email.
Restera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2023 | ||||
| Series C | Apr 21, 2023 | ||||
| Series B | Nov 12, 2021 | ||||
| Series B | Dec 20, 2017 | ||||
| Series A | Jun 29, 2016 |
For institutional investors. Book with your work email.
Restera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| Forepont Capital Partners | Series A, Series B, Series C |
| Aphelion Capital | Series A, Series B, Series C |
| Thiel Capital | Series B |
| GreatPoint Ventures | Series A, Series B |
| Innovation Factory | Series C |
| Eclipse Ventures | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2023
$25M round with DNS Capital and Aphelion Capital.
- Apr 21, 2023
$25M round led by Aphelion Capital and Bonit Capital.
For institutional investors. Book with your work email.
Restera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Restera's valuation, stock price, and market status.
Is Restera a public or private company?
Restera is a private company.
What is the current stock price of Restera?
Restera is a private company, so its shares have no public market price. Caplight tracks Restera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Restera worth (valuation)?
Valuation information for Restera is not publicly available.
Can I buy Restera stock?
Restera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Restera's last funding round?
Restera's most recent funding round was Series A on June 1, 2023.
Who are the main investors in Restera?
Key investors in Restera include GreatPoint Ventures, Forepont Capital Partners, Aphelion Capital, Thiel Capital, GreatPoint Ventures.
Will Restera IPO soon?
No public IPO plans have been announced for Restera.
How can I track Restera secondary market activity?
Caplight tracks bids, offers, and trades in Restera's shares on secondary markets.